48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. More Details
Flawless balance sheet and overvalued.
Share Price & News
How has 48North Cannabis's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NRTH is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: NRTH's weekly volatility has decreased from 16% to 8% over the past year.
7 Day Return
1 Year Return
Return vs Industry: NRTH underperformed the Canadian Pharmaceuticals industry which returned 18.9% over the past year.
Return vs Market: NRTH underperformed the Canadian Market which returned 0.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is 48North Cannabis's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 months ago | Simply Wall StHere's Why We're Watching 48North Cannabis's (CVE:NRTH) Cash Burn Situation
6 months ago | Simply Wall StWhat Kind Of Investor Owns Most Of 48North Cannabis Corp. (CVE:NRTH)?
7 months ago | Simply Wall StWho Has Been Buying 48North Cannabis Corp. (CVE:NRTH) Shares?
Is 48North Cannabis undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate NRTH's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate NRTH's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: NRTH is unprofitable, so we can't compare its PE Ratio to the CA Pharmaceuticals industry average.
PE vs Market: NRTH is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NRTH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NRTH is good value based on its PB Ratio (0.6x) compared to the CA Pharmaceuticals industry average (1.7x).
How is 48North Cannabis forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as 48North Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine 48North Cannabis's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- 48North Cannabis competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has 48North Cannabis performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NRTH is currently unprofitable.
Growing Profit Margin: NRTH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NRTH is unprofitable, and losses have increased over the past 5 years at a rate of 62.8% per year.
Accelerating Growth: Unable to compare NRTH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NRTH is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-45%).
Return on Equity
High ROE: NRTH has a negative Return on Equity (-83.32%), as it is currently unprofitable.
How is 48North Cannabis's financial position?
Financial Position Analysis
Short Term Liabilities: NRTH's short term assets (CA$24.0M) exceed its short term liabilities (CA$8.7M).
Long Term Liabilities: NRTH's short term assets (CA$24.0M) exceed its long term liabilities (CA$755.0K).
Debt to Equity History and Analysis
Debt Level: NRTH is debt free.
Reducing Debt: NRTH had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NRTH has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: NRTH is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.
What is 48North Cannabis's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NRTH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NRTH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NRTH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NRTH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NRTH's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Charles Vennat has been a Director at 48North Cannabis Corp. since May 09, 2020. He is the Chief Executive Officer at 48North Cannabis Corp. since March 09, 2020 and served as its Chief Corporate Offic...
CEO Compensation Analysis
Compensation vs Market: Charles's total compensation ($USD530.88K) is above average for companies of similar size in the Canadian market ($USD166.28K).
Compensation vs Earnings: Insufficient data to compare Charles's compensation with company performance.
|CEO & Director||0.75yr||CA$686.83k||0.42% |
|Chief Financial Officer||2.67yrs||CA$385.99k||0.29% |
|Chief Marketing Officer||1.33yrs||CA$363.98k||0.24% |
|Vice President of Operations||no data||no data||no data|
|Chief Operating Officer||0.42yr||no data||no data|
|Senior Director of Corporate Affairs||no data||no data||no data|
|Senior Vice President of Sales & Commercialization||no data||no data||no data|
|Vice President of Corporate Development||0.92yr||no data||no data|
|Vice President of Human Resources||no data||no data||no data|
Experienced Management: NRTH's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
|CEO & Director||0.75yr||CA$686.83k||0.42% |
|Independent Chairman||2.5yrs||no data||0.48% |
|Independent Director||2.5yrs||no data||0.11% |
|Independent Director||2.5yrs||no data||0.14% |
|Independent Director||2.5yrs||no data||0.18% |
|Director||0.58yr||no data||no data|
|Independent Director||2.5yrs||no data||0.24% |
Experienced Board: NRTH's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: NRTH insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.5%.
48North Cannabis Corp.'s company bio, employee growth, exchange listings and data sources
- Name: 48North Cannabis Corp.
- Ticker: NRTH
- Exchange: TSXV
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$33.796m
- Shares outstanding: 198.80m
- Website: https://www.48nrth.com
Number of Employees
- 48North Cannabis Corp.
- 257 Adelaide Street West
- Suite 500
- M5H 1X9
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NRTH||TSXV (TSX Venture Exchange)||Yes||Common Shares||CA||CAD||Jun 2018|
|NCNN.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Jun 2018|
48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. The company offers bath salts, intimacy oils, flowers, pre-rolls, body cream and oil, vapes, pressed hash,...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/12/03 00:46|
|End of Day Share Price||2020/12/02 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.